Catalyst Wire Dossier Catalyst Wire Dossier

RV568

· Respivert Ltd
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RV568, covering 2011-02-11 to 2013-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers [Phase 1]

See pricing